408 related articles for article (PubMed ID: 22911440)
61. Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Fronkova E; Mejstrikova E; Avigad S; Chik KW; Castillo L; Manor S; Reznickova L; Valova T; Zdrahalova K; Hrusak O; Jabali Y; Schrappe M; Conter V; Izraeli S; Li CK; Stark B; Stary J; Trka J
Leukemia; 2008 May; 22(5):989-97. PubMed ID: 18305563
[TBL] [Abstract][Full Text] [Related]
62. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
[TBL] [Abstract][Full Text] [Related]
63. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
Wang Y; Zeng HM; Zhang LP
Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
[TBL] [Abstract][Full Text] [Related]
64. Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.
Yin MM; Wu RC; Gao J; Hu SY; Liu XM; Zhu XF; Shen SH; Tang JY; Chen J; Hu Q
Curr Med Sci; 2022 Feb; 42(1):201-209. PubMed ID: 34874488
[TBL] [Abstract][Full Text] [Related]
65. Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Gaynon PS; Crotty ML; Sather HN; Bostrom BC; Nachman JB; Steinherz PG; Heerema NA; Sarquis M; Tuel-Ahlgren L; Uckun FM
Leuk Lymphoma; 1997 Jun; 26(1-2):57-65. PubMed ID: 9250788
[TBL] [Abstract][Full Text] [Related]
66. High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.
Iqbal Z; Akhtar T; Awan T; Aleem A; Sabir N; Rasool M; Absar M; Akram AM; Shammas MA; Shah IH; Khalid M; Taj AS; Jameel A; Alanazi A; Gill AT; Hashmi JA; Hussain A; Sabar MF; Khalid AM; Qazi MH; Karim S; Siddiqi MH; Mahmood A; Iqbal M; Saeed A; Irfan MI
Mol Diagn Ther; 2015 Oct; 19(5):277-87. PubMed ID: 26266519
[TBL] [Abstract][Full Text] [Related]
67. Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries.
Siddiqui R; Nancy N; Naing WP; Ali S; Dar L; Khan BK; Padua RA; Carr R
Cancer Genet Cytogenet; 2010 Jul; 200(2):149-53. PubMed ID: 20620598
[TBL] [Abstract][Full Text] [Related]
68. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
[TBL] [Abstract][Full Text] [Related]
69. E2F3a gene expression has prognostic significance in childhood acute lymphoblastic leukemia.
Wang KL; Mei YY; Cui L; Zhao XX; Li WJ; Gao C; Liu SG; Jiao Y; Liu FF; Wu MY; Ding W; Li ZG
Eur J Haematol; 2014 Oct; 93(4):281-9. PubMed ID: 24758291
[TBL] [Abstract][Full Text] [Related]
70. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
[TBL] [Abstract][Full Text] [Related]
71. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
72. [Clinical features of children with relapsed acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol].
Chen XJ; Zou Y; Yang WY; Guo Y; Wang SC; Zhang L; Liu XM; Ruan M; Liu TF; Qi BQ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):321-6. PubMed ID: 25919548
[TBL] [Abstract][Full Text] [Related]
73. [Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement].
Liu F; Chen XJ; Guo Y; Yang WY; Chen X; Zhang XY; Zhang RR; Ren YY; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):896-902. PubMed ID: 33333691
[No Abstract] [Full Text] [Related]
74. Clinical relevance of the fusion transcripts distribution pattern in mexican children with acute lymphoblastic leukemia.
Martinez-Mancilla M; Rodriguez-Aguirre I; Tejocote-Romero I; Medina-Sanson A; Ocadiz-Delgado R; Gariglio P
J Pediatr Hematol Oncol; 2013 Apr; 35(3):170-3. PubMed ID: 23511488
[TBL] [Abstract][Full Text] [Related]
75. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
Conter V; Bartram CR; Valsecchi MG; Schrauder A; Panzer-Grümayer R; Möricke A; Aricò M; Zimmermann M; Mann G; De Rossi G; Stanulla M; Locatelli F; Basso G; Niggli F; Barisone E; Henze G; Ludwig WD; Haas OA; Cazzaniga G; Koehler R; Silvestri D; Bradtke J; Parasole R; Beier R; van Dongen JJ; Biondi A; Schrappe M
Blood; 2010 Apr; 115(16):3206-14. PubMed ID: 20154213
[TBL] [Abstract][Full Text] [Related]
76. [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia].
Yi ZG; Cui L; Gao C; Jin M; Zhang RD; Li ZG; Wu MY
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):170-4. PubMed ID: 21575363
[TBL] [Abstract][Full Text] [Related]
77. Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen.
Brandwein JM; Atenafu EG; Schuh AC; Yee KW; Schimmer AD; Gupta V; Minden MD
Leuk Res; 2014 May; 38(5):532-6. PubMed ID: 24444868
[TBL] [Abstract][Full Text] [Related]
78. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
[TBL] [Abstract][Full Text] [Related]
79. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification.
Maloney K; McGavran L; Murphy J; Odom L; Stork L; Wei Q; Hunger S
Leukemia; 1999 Nov; 13(11):1708-12. PubMed ID: 10557042
[TBL] [Abstract][Full Text] [Related]
80. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
Borowitz MJ; Devidas M; Hunger SP; Bowman WP; Carroll AJ; Carroll WL; Linda S; Martin PL; Pullen DJ; Viswanatha D; Willman CL; Winick N; Camitta BM;
Blood; 2008 Jun; 111(12):5477-85. PubMed ID: 18388178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
